Targeted Radiation Delivery Before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-Term Survivors

Overview of attention for article published in Clinical Cancer Research, November 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 8,561 followers.

Phase 1/2 Study: Radioimmunotherapy Augmented Haploidentical HCT. https://t.co/nsd9O9LBaE https://t.co/1e1ZXaeK2Y

Recent publications @ProvSwedCancRes from the #hemeteam https://t.co/8DkpyLPsiS and https://t.co/yl2b2YLzFo

Orozco et al report on the long-term outcomes of a phase 1/2 study using Iodine-131-anti-CD45 radioimmunotherapy prior to haploidentical #HematopoieticCellTransplantation in patients with acute myeloid or lymphoid leukemia. https://t.co/vsivhUczdS @Sand…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.